200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 138356-20-4

138356-20-4

138356-20-4 | 1,2-Ethanediamine, N1-[2-(3,4-dichlorophenyl)ethyl]-N1,N2,N2-trimethyl-

CAS No: 138356-20-4 Catalog No: AG0018MI MDL No:

Product Description

Catalog Number:
AG0018MI
Chemical Name:
1,2-Ethanediamine, N1-[2-(3,4-dichlorophenyl)ethyl]-N1,N2,N2-trimethyl-
CAS Number:
138356-20-4
Molecular Formula:
C13H20Cl2N2
Molecular Weight:
275.2173
IUPAC Name:
N'-[2-(3,4-dichlorophenyl)ethyl]-N,N,N'-trimethylethane-1,2-diamine
InChI:
InChI=1S/C13H20Cl2N2/c1-16(2)8-9-17(3)7-6-11-4-5-12(14)13(15)10-11/h4-5,10H,6-9H2,1-3H3
InChI Key:
MGVRNMUKTZOQOW-UHFFFAOYSA-N
SMILES:
CN(CCc1ccc(c(c1)Cl)Cl)CCN(C)C
UNII:
1S3X75QGDO

Properties

Complexity:
212  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
274.1g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
275.217g/mol
Monoisotopic Mass:
274.1g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
6.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.5  

Literature

Title Journal
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters 20130801
Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20120401
Influence of sigma-1 receptor modulators on ethanol-induced conditioned place preference in the extinction-reinstatement model. Behavioural pharmacology 20120201
(+)-Morphine attenuates the (-)-morphine-produced tail-flick inhibition via the sigma-1 receptor in the mouse spinal cord. Life sciences 20111205
Chloroquine inhibits glutamate-induced death of a neuronal cell line by reducing reactive oxygen species through sigma-1 receptor. Journal of neurochemistry 20111101
Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation. Psychopharmacology 20111001
Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors. The Journal of pharmacology and experimental therapeutics 20111001
Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors. The Journal of pharmacology and experimental therapeutics 20111001
Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats. Drug and alcohol dependence 20110901
The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine. Drug and alcohol dependence 20110701
Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biological psychiatry 20110201
Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Pharmacology 20110101
Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants. Journal of pharmacological sciences 20110101
Effect of acute topical application of +-pentazocine on the mechanical allodynia in diabetic mice. European journal of pharmacology 20100901
Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration. Blood 20100610
Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Molecular pharmacology 20100401
SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression. Neuroscience letters 20100129
The Antinociceptive Effect of Sigma-1 Receptor Antagonist, BD1047, in a Capsaicin Induced Headache Model in Rats. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20091201
Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090701
Sigma-1 receptors are essential for capsaicin-induced mechanical hypersensitivity: studies with selective sigma-1 ligands and sigma-1 knockout mice. Pain 20090601
Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors. British journal of pharmacology 20090601
Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090501
Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice. Psychopharmacology 20090501
Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats. Journal of neurochemistry 20090501
Antidepressant-like effect of PRE-084, a selective sigma1 receptor agonist, in Albino Swiss and C57BL/6J mice. Pharmacological reports : PR 20090101
Intrathecal administration of sigma-1 receptor agonists facilitates nociception: involvement of a protein kinase C-dependent pathway. Journal of neuroscience research 20081201
Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction. Investigative ophthalmology & visual science 20081101
Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain. Anesthesiology 20081101
Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. Journal of psychopharmacology (Oxford, England) 20080801
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundamental & clinical pharmacology 20080801
Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. British journal of pharmacology 20080701
Anti-inflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice. British journal of pharmacology 20080701
sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation. Investigative ophthalmology & visual science 20080601
A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect. Life sciences 20080312
Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation. Journal of neurochemistry 20080101
Effects of selective sigma receptor ligands on glucocorticoid receptor-mediated gene transcription in LMCAT cells. Pharmacological reports : PR 20080101
Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. The European journal of neuroscience 20071201
Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20071101
Protective effects of the sigma agonist Pre-084 in the rat retina. The British journal of ophthalmology 20071001
Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse. European journal of pharmacology 20071001
(+)-Morphine and (-)-morphine stereoselectively attenuate the (-)-morphine-produced tail-flick inhibition via the naloxone-sensitive sigma receptor in the ventral periaqueductal gray of the rat. European journal of pharmacology 20070924
Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070901
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine. Neuroscience letters 20070615
Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine. European journal of pharmacology 20070601
dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat. European journal of pharmacology 20070521
Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats. Neurochemistry international 20070501
Novel sigma receptor ligands: synthesis and biological profile. Journal of medicinal chemistry 20070308
Antidepressant-like effect of combined treatment with selective sigma receptor agonists and a 5-HT1A receptor agonist in the forced swimming test in rats. Pharmacological reports : PR 20070101
Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. The Journal of pharmacology and experimental therapeutics 20061201
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. British journal of pharmacology 20061201
Sigma1 receptor ligands and related neuroactive steroids interfere with the cocaine-induced state of memory. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060701
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. International immunopharmacology 20060601
Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. British journal of pharmacology 20060601
The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20060601
Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil. The Journal of pharmacology and experimental therapeutics 20060501
Sigma receptor ligands protect human retinal cells against oxidative stress. Neuroreport 20060227
Compensatory effect by sigma1 (sigma1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task. Behavioural brain research 20060106
Effect of BD 1047, a sigma1 receptor antagonist, in the animal models predictive of antipsychotic activity. Pharmacological reports : PR 20060101
Presynaptic modulation of synaptic transmission by pregnenolone sulfate as studied by optical recordings. Journal of neurophysiology 20051201
Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. Journal of leukocyte biology 20051201
Neuroactive steroids protect retinal pigment epithelium against oxidative stress. Neuroreport 20050801
The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via sigma1 receptor activation: comparison with the effects of dextromethorphan. British journal of pharmacology 20050401
Sigma receptor antagonists inhibit human lens cell growth and induce pigmentation. Investigative ophthalmology & visual science 20050401
Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma 1 receptors of guinea pig brain. Synapse (New York, N.Y.) 20050301
Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites. European journal of pharmacology 20040913
The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology 20040901
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer research 20040715
Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol. Brain research 20040611
Cocaine modulates cytokine and enhances tumor growth through sigma receptors. Journal of neuroimmunology 20040201
Antitussive activity of sigma-1 receptor agonists in the guinea-pig. British journal of pharmacology 20040101
Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. The Journal of neuroscience : the official journal of the Society for Neuroscience 20030501
Sigma sites mediate DTG-evoked hypothermia in rats. Pharmacology, biochemistry, and behavior 20021101
Involvement of the sigma receptor in passive-avoidance learning in the day-old chick during the second wave of neuronal activity. Neurobiology of learning and memory 20010501
Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 20000911
Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. European journal of pharmacology 19990416
Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. European journal of pharmacology 19950714

© 2019 Angene International Limited. All rights Reserved.